Literature DB >> 2373664

Comparative in-vivo activity of clotrimazole and a clotrimazole/hydrocortisone combination in the treatment of experimental dermatophytosis in guinea pigs.

G S Shankland1, M D Richardson.   

Abstract

To compare the activity of clotrimazole with a clotrimazole/hydrocortisone combination, guinea pigs were infected with Trichophyton mentagrophytes var. mentagrophytes. The animals were treated with once daily application of clotrimazole alone, hydrocortisone alone, base alone or a combination of clotrimazole and hydrocortisone. One group of animals was left untreated. Daily clinical observations were made. At intervals during the three week study animals were killed, skin scrapings were taken for microscopical examination and culture and skin was removed for histological examination. The responses of the guinea pigs treated with the base alone reflected those of the untreated controls. They were mycologically positive throughout the study and showed extensive inflammatory reactions on histology. Animals treated with hydrocortisone alone rapidly developed a severe clinical infection and mycological examination was positive throughout. Animals treated with clotrimazole alone did not show severe clinical reactions and were negative on culture after four treatments; histology showed inflammatory scabs after resolution of infection. Clinically, the animals receiving combination therapy improved most quickly and cultures were negative after two treatments. Histological examination showed resolution of the infection and little inflammation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373664     DOI: 10.1093/jac/25.5.825

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  1 in total

1.  Topical anti-inflammatory properties of flutrimazole, a new imidazole antifungal agent.

Authors:  M Merlos; M L Vericat; J García-Rafanell; J Forn
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.